Myko San

Myko San is a specialized biotechnology company based in Croatia that focuses on the development and production of high-quality medicinal mushroom extracts. Founded in 1990 by Dr. Ivan Jakopovich, the company is a pioneer in the professional application of mycotherapy, blending traditional knowledge with modern scientific research. Their product line, including flagship extracts like Agarikon.1 and Mykoprotect.1, is designed to provide supportive care for serious conditions such as cancer and chronic viral infections. Myko San distinguishes itself through a commitment to scientific validation, having conducted numerous clinical and cohort studies in collaboration with academic institutions. The company serves a global market, providing evidence-based fungal supplements aimed at immune system modulation and overall health improvement.